Startups
Ectica Technologies AG is a Swiss supplier of hydrogel-based tools to the biopharmaceutical industry and bioresearch institutes. Our patented 3DProSeed technology combines the biological relevance of cell-based assays in hydrogels with the highest workflow integration level in drug discovery.
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| VentureLab | venturelab.swiss |
Mentions in press and media 7
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 12, 2019 | SEED Biosciences and Andrew Alliance receive innovation awards in Washington | |
| Aug 13, 2018 | Ectica Technologies wins Merck as a customer | |
| Mar 27, 2017 | Ectica selected for Merck Accelerator | |
| Oct 6, 2016 | Three new CTI Start-up Label companies | |
| Jan 22, 2016 | Bio- and MedTech enterprises have their momentum in Ticino | |
| Jun 9, 2015 | Startups für St. Galler Investor Forum stehen fest |
Reviews 0
FAQ about Ectica Technologies AG
Who has invested in Ectica Technologies AG?
Parsers VC lists 2 investors of Ectica Technologies AG, among them VentureLab.
What has the press written about Ectica Technologies AG?
Parsers VC has collected 7 articles mentioning Ectica Technologies AG, among them “SEED Biosciences and Andrew Alliance receive innovation awards in Washington” (Feb 12, 2019) and “Ectica Technologies wins Merck as a customer” (Aug 13, 2018).
Is Ectica Technologies AG still active?
Yes, Ectica Technologies AG is active; its latest activity on Parsers VC dates from Jan 2, 2024.